Kodiak Sciences Inc. (KOD)
BMV
Closed
Aug 21, 2026
Day's Range
749.0052 wk Range
51.00Overview - KOD - Kodiak Sciences Inc.
Key Statistics
Valuation
Enterprise Value
793.69B
P/E (Trailing)
‪-173.37‬
PEG Ratio
‪12.59‬
Price / Book
‪32.95‬
EV / EBITDA
‪-203.07‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.44%‬
Return on Equity
‪-368.37%‬
Ownership
Shares Outstanding
62.15M
Float
39.55M
Held by Insiders
‪5.16%‬
Held by Institutions
‪102.38%‬
Price stats
Beta
‪2.20‬
50-Day Avg
‪749.00‬
200-Day Avg
‪538.13‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KOD - Kodiak Sciences Inc.
Peers - KOD - Kodiak Sciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- KODBMVKodiak Sciences Inc.47.07BMarket Cap+93.19%52-week change-173.38P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.44P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.215.02BMarket Cap+3.02%52-week change176.04P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.49P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - KOD - Kodiak Sciences Inc.
About
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics for retinal diseases. The company specializes in next-generation therapies targeting chronic, high-prevalence ophthalmic conditions that lead to vision loss, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
